Project Description

TCELLEREX is Tailored Therapeutics’ platform for delivery of tumor reactive T-cells for adoptive cell therapy (ACT).  TCELLEREX has application across multiple tumor types, including solid tumors.  The technology leverages proprietary biomarkers to select the T-cells from the patient’s peripheral blood or tumor most likely to have reactivity with patient’s tumor.  Selected T-cells are expanded and returned for infusion to the patient.